Startup India Government of India
Remeris Pharma Private Limited
Remeris Pharma Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹27.93 Lakh
▼ 2% YoY
Net profit · FY 2024
₹1.68 Lakh
Net margin 6%
EBITDA · FY 2024
₹1.84 Lakh
EBITDA margin 6.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Remeris Pharma Private Limited
Data last updated:
Remeris Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24119GJ2020PTC112272. Its GSTIN is 24AAKCR0432L1ZE (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bharat Harivallavdas Shah and Dhaval Rajnikant Zaveri.
Its last annual general meeting (AGM) was held on 03 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T.F. 305 Safron Complex Opp. Camps Corner Fatehgunj, Vadodara, Gujarat, India – 390002.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.93 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.68 Lakh (net margin 6%) and EBITDA of ₹1.84 Lakh (EBITDA margin 6.6%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years.
The company is associated with 1 brand: Remerispharma. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Remeris Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0027916).
Company details
CIN U24119GJ2020PTC112272
Registration Number 112272
Incorporation Date 24 January 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0027916
Key People
Bharat Harivallavdas Shah Director Dhaval Rajnikant Zaveri Director Piyush Chaturbhai Patel Director Recognitions & Rankings of Remeris Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0027916
Contact details
Remeris Pharma Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressT.F. 305 Safron Complex Opp. Camps Corner Fatehgunj, Vadodara, Gujarat, India – 390002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Remeris Pharma Private Limited, buy the company report.
Comprehensive company report
Remeris Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Remeris Pharma operates one associated brand: Remerispharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, markets, and supplies pharmaceutical products for health needs worldwide. | remerispharma.com |
Business activity
The main business activity of Remeris Pharma is manufacturing. In detail, this covers wood and wood products, furniture, paper and paper products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C3 | Wood and wood products, furniture, paper and paper products |
To see the full business activity and turnover split of Remeris Pharma Private Limited, buy the company report.
Financials of Remeris Pharma Private Limited
FY 2025 filings availableRemeris Pharma Private Limited reported revenue of ₹27.93 Lakh (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹27.93 Lakh ▼ 2%
Net profit · FY 2024
₹1.68 Lakh margin 6%
EBITDA · FY 2024
₹1.84 Lakh margin 6.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 445%
3 years · compounded
▼ 37%
Revenue has declined at a compounded annual rate (CAGR) of 19% over three years, including a 2% fall in the latest year. EBITDA rose 445% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Remeris Pharma Private Limited, buy the company report.
Board of directors of Remeris Pharma Private Limited
Remeris Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Harivallavdas Shah | Director | 28 Jan 2022 | 4 Years 9 Months | Current |
| Dhaval Rajnikant Zaveri | Director | 28 Jan 2022 | 4 Years 9 Months | Current |
| Piyush Chaturbhai Patel | Director | 24 Jan 2020 | 6 Years 9 Months | Current |
| Dhavalkumar Chhotalal Barot | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Remeris Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wood and wood products, furniture, paper and paper products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaniyarakkal Wood Point Private Limited | ₹28.14 Lakh (FY 2024) | Muzhappala, Kerala, India | ||||
| Paradise Health Care Private Limited | ₹28.09 Lakh (FY 2025) | 11.0% | Kalyani, West Bengal, India | |||
| Av Labels Solution India Private Limited | ₹28.06 Lakh (FY 2023) | 3642.0% | Dadri, Uttar Pradesh, India | |||
| Neopia Solutions Private Limited | ₹27.94 Lakh (FY 2019) | Chennai, Tamil Nadu, India | ||||
| Guru Precision Tools Private Limited | ₹27.93 Lakh (FY 2018) | 33.0% | Bangalore, Karnataka, India | |||
| Remeris Pharma Private Limitedthis company | ₹27.93 Lakh (FY 2024) | ₹1.68 Lakh | 6% | -2.0% | Vadodara, Gujarat, India | |
| Aadya Furnitures Private Limited | ₹27.84 Lakh (FY 2017) | Lucknow, Uttar Pradesh, India | ||||
| Saikrupa Packaging Private Limited | ₹27.71 Lakh (FY 2019) | -74.0% | Chennai, Tamil Nadu, India | |||
| Zraya Custom Furniture Private Limited | ₹27.68 Lakh (FY 2019) | 118.0% | Bangalore, Karnataka, India | |||
| Shiv Sai Packaging Private Limited | ₹27.64 Lakh (FY 2017) | -3.0% | Delhi, India | |||
| GSB Forms Private Limited | ₹27.55 Lakh (FY 2025) | 10.0% | Cuttack, Odisha, India |
To see the full peer comparison of Remeris Pharma Private Limited, buy the company report.
Auditor
Remeris Pharma Private Limited is audited by AMIT R SONI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT R SONI & ASSOCIATES | FY 2020 | 144765W |
Shareholding
The shareholding of Remeris Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Remeris Pharma Private Limited, buy the company report.
Legal cases
Remeris Pharma Private Limited has 1 court case on record: 1 filed by Remeris Pharma. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bharuch, Gujarat | Civil suit | Filed by the company against Norris Medicines Limited and 4 others | Pending |
To see the full case history of Remeris Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Remeris Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Remeris Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCR0432L1ZE | Gujarat | Active | 07 Feb 2020 |
To see the full GST registrations and return filing status of Remeris Pharma Private Limited, buy the company report.
Recent activity
Remeris Pharma Private Limited has 8 board changes on record since 2020: 4 appointments and 4 cessations. The latest: Bharat Harivallavdas Shah ceased to be Additional Director on 30 Sep 2022.
AGM
Remeris Pharma Private Limited last Annual general meeting of members was held on 03 Oct 2025 as per latest MCA records.
Filing
Remeris Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Bharat Harivallavdas Shah ceased to be Additional Director.
Ceased
Dhaval Rajnikant Zaveri ceased to be Additional Director.
Appointed
Bharat Harivallavdas Shah was appointed as Director.
Appointed
Dhaval Rajnikant Zaveri was appointed as Director.
Ceased
Rashmi Piyshbhai Patel ceased to be Director.
Ceased
Dhavalkumar Chhotalal Barot ceased to be Additional Director.
Appointed
Dhavalkumar Chhotalal Barot was appointed as Director.
Appointed
Piyush Chaturbhai Patel was appointed as Director.
Incorporation
24 Jan 2020
Remeris Pharma Private Limited was registered on 24 Jan 2020 with Roc Ahmedabad & aged 6 years 9 months as per MCA records.
Frequently asked questions
Remeris Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 January 2020 (6+ years old) and is registered under CIN U24119GJ2020PTC112272.
Remeris Pharma has 4 current directors:
- Bharat Harivallavdas Shah - Director
- Dhaval Rajnikant Zaveri - Director
- Piyush Chaturbhai Patel - Director
- Dhavalkumar Chhotalal Barot - Director
The latest financial statements of Remeris Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 03 October 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Remeris Pharma is 24AAKCR0432L1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Remeris Pharma is U24119GJ2020PTC112272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Remeris Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Remeris Pharma was incorporated on 24 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Remeris Pharma by revenue are Kaniyarakkal Wood Point Private Limited, Paradise Health Care Private Limited, Av Labels Solution India Private Limited, Neopia Solutions Private Limited, Guru Precision Tools Private Limited and 5 more, all in the same principal business activity (wood and wood products, furniture, paper and paper products).
Bharat Harivallavdas Shah ceased to be Additional Director on 30 Sep 2022. Dhaval Rajnikant Zaveri ceased to be Additional Director on 30 Sep 2022. Bharat Harivallavdas Shah was appointed as Director on 28 Jan 2022. Remeris Pharma has 8 board changes on record in total.
Yes, Remeris Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Remeris Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0027916).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages